Man becomes 1st in New York to be cured of sickle cell

Long Island man is first in New York history to be cured of sickle cell anemia
A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. Medical history made at Cohen Children's Medical Center For 21 years,
Man Cured Of Sickle Cell Disease In New York Thanks To New Gene Therapy
NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle cell anemia.
Long Island patient gets breakthrough sickle cell treatment called a ‘cure’: ‘I’m not in pain anymore’
A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first
Man becomes first in New York to be cured of sickle cell
LONG ISLAND, NY (WCBS) - A 21-year-old man has become the first in New York to be cured of sickle cell anemia. “We feel blessed to be the first to be able to offer this,” said Dr. Jonathan Fish with the Cohen Children’s Medical Center.
Pioneering the world’s first CRISPR medicine for sickle cell disease
When Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters was with a 24-year-old patient whose sickle cell disease left them with almost weekly pain episodes.
Sickle cell gene therapy frees teen from life of pain
Aaron Scott, of Fayetteville, is the first in North Carolina to receive a new FDA-approved therapy which uses the patient's own cells to relieve the pain of sickle cell disease.
Sickle-cell anemia patient reunites with Long Island doctors whose gene therapy treatments made him symptom-free
Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after undergoing Lyfgenia, a new type of gene therapy.
MedPage Today on MSN2d
Approved Sickle Cell Drug Fails to Beat Placebo in Trial
Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
'Common disease took my sight and ate my body - it takes 130 people to keep me alive'
Amid a genetic breakthrough in the treatment of sickle cell disease, The Mirror investigates the agonising reality of living ...
Proposed NJ bill could allow medical cannabis for sickle cell patients
Anyone living with sickle cell anemia is a warrior, Leslie Davis-Primo will tell you. “I’ve had three children, largely ...
Sickle Cell Disease News2d
Hydroxyurea may reduce stroke risk in sickle cell disease children
Researchers studied the efficacy of hydroxyurea at reducing stroke risk in sickle cell anemia, the most common and severe ...